CRISPR Technology Market Report 2022: Widespread Potential Applications Generate Opportunities –


DUBLIN–(BUSINESS WIRE)–The report “CRISPR Technology Market, By Product, By Application, By End-User, And By Geography – Size, Share, Outlook, and Opportunity Analysis, 2022-2028” has been added to from offer.

CRISPR technology is advancing genome editing in the fields of medicine, pharmacy, biotechnology and agriculture, which has enabled scientists to conduct research in these fields through genome editing more faster and more efficient worldwide. CRISPR is also used to correct genetic defects, treat human diseases and produce better crop varieties.

It has a number of potential applications which include treating and preventing the spread of disease, correcting genetic defects and also crop improvement. The CRISPR-Cas9 system has a wide variety of applications. In medicine, it has been applied in research related to cancer, viral infections, genetic diseases, and detection of pathogens. CRISPR is a technology that can be used to edit genes and as such will likely change the world.

Market dynamics:

COVID-19 outbreak across the globe, growing number of ongoing clinical trials, and expanding gene-editing tool research are major factors that are expected to increase the growth of the global CRISPR technology during the forecast period. For example, in March 2020, scientists at the University of Toronto developed CHyMERA, a CRISPR-based tool for more versatile genome editing.

CRISPR technology has great potential for application in both prevention and control of COVID-19. In March 2020, researchers at the New York Genome Center developed new CRISPR screening technology to target RNA, including RNA from novel viruses (COVID-19). Additionally, in November 2019, researchers at ETH Zurich, Switzerland swapped the enzyme CAS9 for CAS 12a, which allowed the researchers to modify genes in 25 target sites.

Main characteristics of the study:

  • This report provides an in-depth analysis of the global CRISPR technology market and provides the market size (Million US$) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the reference year.

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

  • This study also provides key insights into the market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.

  • It profiles leading players of the global CRISPR technology market based on the following parameters such as company highlights, product portfolio, key highlights, financial performance and strategies.

  • The main companies covered in this study are Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies), among others

  • The information in this report would enable marketers and managing authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion and marketing tactics.

  • The Global CRISPR Technology Market report is targeted at various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

  • Stakeholders would have an ease in making decisions through various strategy matrices used to analyze the global CRISPR technology market.

Detailed Segmentation: Global CRISPR Technology Market, by Product:

  • enzymes

  • Kits and reagents

  • guide RNA

  • Others

Global CRISPR Technology Market, By Application:

  • Biomedical

  • Agricultural

  • Industrial

  • Others

Global CRISPR technology market, by end user:

  • Pharmaceutical companies and biotechnology companies

  • Academics and government research institutes

  • Others (CRO, etc.)

Global CRISPR technology market, by geography:

  • North America

  • Europe

  • Asia Pacific

  • Middle East and Africa

  • South America

Main topics covered:

1. Research objectives and hypotheses

2. Competence of the market

3. Market dynamics, regulation and trend analysis

  • Market dynamics

  • Growing demand and adoption of CRISPR

  • High cost of CRISPR

  • The COVID-19 epidemic (global pandemic)

  • Impact analysis

  • Highlights

  • Regulatory scenario

  • Product Launch/Approvals

  • PEST analysis

  • PORTER’s analysis

  • Merger and acquisition scenario

4. Global CRISPR Technology Market – Impact of Coronavirus (COVID-19) Pandemic

5. Global CRISPR technology market, by product, 2017-2028, (USD Million)

6. Global CRISPR technology market, application, 2017-2028, (USD Million)

7. Global CRISPR technology market, by end-user, 2017-2028, (USD Million)

8. Global CRISPR technology market, by geography, 2017-2028, (USD Million)

9. Competitive Landscape

10. Branch

Companies cited

  • Merck KGaA

  • Thermo Fisher Scientific

  • Origen Technologies Inc.

  • New England Biolabs

  • GenScript

  • GeneCopée Inc.

  • Cellecta Inc.

  • Agilent Technologies Inc.

  • Perkin Elmer

  • Inc. (Horizon Discovery Ltd.)

  • Danaher Corporation (integrated DNA technologies)

For more information about this report visit

See also  As more coupons move online, older, low-income shoppers are being left behind